Updated on: 4 April 2018

Roles in: Health Equity

1. In the past 36 months have you accepted the following from a commercial organisation with a financial interest in the broad topic area of the Group/Unit?

a) Support for attending meetings, including sabbaticals and study tours (this covers travel, accommodation and/or hospitality)?
Yes - Travel and accommodation for OMERACT meetings- a registered non-profit independent medical research organization, OMERACT, whose goal is to improve and advance the health outcomes for patients suffering from musculoskeletal conditions. OMERACT receives unrestricted educational grants from the American College of Rheumatology, European League of Rheumatology and several pharmaceutical companies listed below which is used to support fellows, international patient groups and support a major international biennial conference which results in many peer-reviewed publications; Amgen, Astra Zeneca,Bristol Myers Squibb, Celgene, Eli Lilly, Genentech/ Roche, Genzyme / Sanofi, Horizon Pharma Inc., Merck, Novartis , Pfizer, PPD, Quintiles, Regeneron, Savient, Takeda Pharmaceutical, UCB Group, Vertex, Forest, Bioiberica.

b) Payment or honoraria for lectures, presentations, speaker bureaus, manuscript writing, or educational events?
No

c) Fees for organising education?
Yes - Yes, I'm [unpaid] Chair of the Management SubCommittee of the Executive Committee of a registered non-profit independent medical research organization, OMERACT, whose goal is to improve and advance the health outcomes for patients suffering from musculoskeletal conditions. OMERACT receives unrestricted educational grants from the American College of Rheumatology, European League of Rheumatology and several pharmaceutical companies listed below which is used to support fellows, international patient groups and support a major international bi-annual conference which results in many peer-reviewed publications; Amgen, Astra Zeneca,Bristol Myers Squibb, Celgene, Eli Lilly, Genentech/ Roche, Genzyme / Sanofi, Horizon Pharma Inc., Merck, Novartis , Pfizer, PPD, Quintiles, Regeneron, Savient, Takeda Pharmaceutical, UCB Group, Vertex, Forest, Bioiberica.

d) Grants and contracts?
No

e) Funds for a member of staff?
No

f) Fees for consulting?
Yes - An independent Committee Member for clinical trial Data Safety Monitoring Boards for FDA approved trials being conducted by: - UCB Biopharma GmbH & SPRL, - Parexel International, - Prahealth Sciences - Reformulary Group Providing independent medical consultation professional services to the following firms: - CHEOR Solutions (Canada) Ltd., - Innovative Science Solutions LLC An advisory committee member of the of the Canadian Reformulary Group Inc., a company that reviews the evidence for health insurance companies employer drug plans.

g) Royalty or licences payments?
Yes - Yes, contributing author/ editor for journals. textbooks and articles published by: Elsevier, Little Brown, Wolters Kluwer Ltd. and John Wiley & Sons Ltd.

2. In the past 36 months have you, your spouse/partner or an immediate family member been employed by or do you or they own a commercial organization with a financial interest in the broad topic area of the Group/Unit?
No

3. Do you own stocks or shares in a commercial organization with a financial interest in the broad topic area of the Group/Unit?
No

4. Do you hold any patents (planned, issued or pending) for products relevant to the broad topic area of the Group/Unit?
No

5. Do you have any other competing interests (financial or non-financial)?
Yes - Am an un-paid Board Advisory Member of the Ontario Rheumatology Association Ontario Biologics Registry Initiative Council.